Department of Pharmaceuticals
Government
Open

PRIP Call 2 — Up to ₹100 Cr Grants for Pharma & MedTech R&D — Eligibility Criteria

Eligibility

PRIP Call 2 — Up to ₹100 Cr Grants for Pharma & MedTech R&D is open to idea · product-stage startups registered in India. The full eligibility criteria — qualifying sectors, states and entity types — are below.

Who can apply

The applicant entity must be registered in India. Qualifying forms include a company incorporated under the Companies Act, a limited liability partnership, or a registered partnership firm. One Person Companies, Section 8 companies, and sole proprietorships are excluded.

  • Early-Stage Track applicants must hold either a valid DPIIT startup recognition certificate or an Udyam Registration Certificate.
  • Individuals, unregistered entities, and academic institutions cannot apply in their own name. Ecosystem enablers may submit on behalf of projects or entities within their network.
  • Projects should generally fall between TRL 1 and TRL 6. Anything already at TRL 7 or above is not eligible.
  • An applicant is disqualified if its key managerial personnel have a conviction for moral turpitude or corruption, or if the entity is undergoing insolvency proceedings.
  • A project already submitted under PRIP Round 1 cannot be sent in again if it is the same project.

PRIP Call 2 — Up to ₹100 Cr Grants for Pharma & MedTech R&D is open to startups at the idea and product stage working in health lifesciences. It is open to startups registered anywhere in India. Applicants should be registered as private limited, llp and partnership.

ideaproducthealth lifesciences
Eligible stage
Idea · Product
Location
Open to startups registered in India
Entity type
Private Limited, Llp, Partnership

← Back to PRIP Call 2 — Up to ₹100 Cr Grants for Pharma & MedTech R&D overview